Aster JC, Stone RM. Clinical manifestations, diagnosis, and classification of myelodysplastic syndromes (MDS). UpToDate. 2024. Accessed at https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-classification-of-myelodysplastic-syndromes-mds on June 28, 2024.
Churpek JE, Godley LA. Familial disorders of acute leukemia and myelodysplastic syndromes. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/familial-disorders-of-acute-leukemia-and-myelodysplastic-syndromes on June 28, 2024.
National Cancer Institute. Myelodysplastic Syndromes Treatment (PDQ?)–Health Professional Version. 2022. Accessed at https://www.cancer.gov/types/myeloproliferative/hp/myelodysplastic-treatment-pdq on June 28, 2024.
SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2024 Apr 17. [updated: 2024 Jun 27; cited 2024 Jun 27]. Accessed at https://seer.cancer.gov/statistics-network/explorer/ on June 28, 2024.
Steensma DP, Stone RM. Chapter 96: Myelodysplastic syndromes. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier; 2020.
Zhang Y, LeBeau MM. Cytogenetics, molecular genetics, and pathophysiology of myelodysplastic syndromes/neoplasms (MDS). UpToDate. 2024. Accessed at https://www.uptodate.com/contents/cytogenetics-molecular-genetics-and-pathophysiology-of-myelodysplastic-syndromes-neoplasms-mds on June 28, 2024.